Raymond James Financial Services Advisors’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
CII
CS
Raymond James Financial Services Advisors's BNTX Position: Q3 2024 in Review
Raymond James Financial Services Advisors reduced its BioNTech (BNTX) stake by 12% in Q3 2024, selling an estimated $41.1K and leaving 3,301 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #2780.
Raymond James Financial Services Advisors first reported a position in BNTX in Q2 2020 and has held it in 18 quarters since. The position peaked at $2.49M in Q3 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.
- Raymond James Financial Services Advisors held 3,301 shares of BioNTech worth $392K as of Q3 2024.
- Raymond James Financial Services Advisors sold 447 BioNTech shares in Q3 2024, an estimated $41.1K.
- BioNTech made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2780 holding.
- Raymond James Financial Services Advisors first reported a position in BioNTech in Q2 2020 and has held it in 18 quarters since.
- Raymond James Financial Services Advisors's BioNTech position peaked at $2.49M in Q3 2021.
- 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.